Navigating the Complex Treatment Landscape in Relapsed/Refractory Myeloma

Download All
Review the latest evidence-based strategies on individualized treatment of relapsed/refractory multiple myeloma with downloadable slides, a podcast, and an on-demand webcast from a live CCO webinar.
Paul G. Richardson, MD
Program Director
Natalie S. Callander, MD
Noopur Raje, MD

On-Demand Webcast

In this on-demand webcast from a live webinar, Paul G. Richardson, MD; Natalie S. Callander, MD; and Noopur Raje, MD, discuss recent advances in new and emerging therapies for patients with relapsed/refractory multiple myeloma.

Paul G. Richardson, MD
Program Director
Natalie S. Callander, MD Noopur Raje, MD
Physicians: maximum of 1.0 AMA PRA Category 1 Credit Released: October 12, 2022 Expired: October 11, 2023
Provided by Medical Learning Institute, Inc. in partnership with Clinical Care Options, LLC.

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC
Karyopharm Therapeutics Inc.
Regeneron Pharmaceuticals, Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings